Barclays analyst Balaji Prasad maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) today and set a price target of $28.00.

--Nokia's fourth-quarter sales should be supported by light comparables, while a favorable mix and cost-saving measures are expected to support a strong margin expansion, Sebastien Sztabowicz at ...

Several arenas and venues across the UK and Europe have earned A Greener Future (AGF) certification by demonstrating their ...

The latest Market Talks covering Financial Services. Exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ...

Intel's future is uncertain after CEO's retirement, raising questions about potential split and financial advantage. Read ...

Detailed price information for Bank of America Corp (BAC-N) from The Globe and Mail including charting and trades.

SAN JOSE, Calif. - Lumentum Holdings Inc . (NASDAQ: NASDAQ:LITE), a $5.1 billion market cap designer and manufacturer of optical and photonic products, has announced that the Science-Based Targets ...

NEW YORK (AP) — The NBA is using the two-night draft format again this year, announcing Tuesday that the 2025 event will take ...

Paris Saint-Germain are reportedly showing interest in Aston Villa forward Jhon Durán as they look to strengthen their attack ...

Prediction for the UEFA Champions League match which will take place on January 29. Who will turn out to be stronger? Check ...

Tuttosport newspaper reports that Napoli won't send an improved offer for Alejandro Garnacho, setting the maximum bid to €50m ...

Get ready for the 2025 Premier League darts season with our 56-page publication - available to buy now - with exclusive ...